Arbutus Biopharma Corporation (ABUS)
NASDAQ · Healthcare
Arbutus Biopharma Corporation Total Liabilities 2011–2025
Arbutus Biopharma Corporation annual/quarterly total liabilities history from 2013 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Arbutus Biopharma Corporation total liabilities for the quarter ending December 31, 2025 were 18.0M, a 47.46% decrease year-over-year.
- Arbutus Biopharma Corporation total liabilities for 2025 were 18.0M, a 47.46% decrease from 2024.
- Arbutus Biopharma Corporation total liabilities for 2024 were 34.3M, a 10.53% decrease from 2023.
- Arbutus Biopharma Corporation total liabilities for 2023 were 38.4M, a 34.46% decrease from 2022.
- Arbutus Biopharma Corporation total liabilities for 2022 were 58.6M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Arbutus Biopharma Corporation Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $18 |
| 2024 | $34 |
| 2023 | $38 |
| 2022 | $59 |
| 2021 | $35 |
| 2020 | $35 |
| 2019 | $33 |
| 2018 | $28 |
| 2017 | $55 |
| 2016 | $73 |
| 2015 | $165 |
| 2014 | $30 |
| 2013 | $13 |
| Arbutus Biopharma Corporation Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $18 |
| 2024-12-31 | $34 |
| 2023-12-31 | $38 |
| 2022-12-31 | $59 |
| 2021-12-31 | $35 |
| 2020-12-31 | $35 |
| 2019-12-31 | $33 |
| 2018-12-31 | $28 |
| 2017-12-31 | $55 |
| 2016-12-31 | $73 |
| 2015-12-31 | $165 |
| 2014-12-31 | $30 |
| 2013-12-31 | $13 |
Arbutus Biopharma Corporation Total Liabilities — FAQ
Arbutus Biopharma Corporation (ABUS) total liabilities over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABUS's total liabilities history?
The chart and table above show Arbutus Biopharma Corporation's total liabilities by year and by quarter, including the growth rate.